![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Acromegaly - Symptoms and causes - Mayo Clinic
2024年2月6日 · Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When you have too much growth hormone, your bones increase in size. In childhood, this leads to increased height and is called gigantism.
Acromegaly - Diagnosis and treatment - Mayo Clinic
2024年2月6日 · For acromegaly, some basic questions to ask your doctor include: What's the most likely cause of my symptoms? Other than the most likely cause, what are possible causes for my symptoms or condition?
Acromegaly - Doctors and departments - Mayo Clinic
2024年2月6日 · It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach.
Illustration showing person with acromegaly - Mayo Clinic
Symptoms of acromegaly include an enlarged face and hands. Changes to the face may cause the brow bone and lower jawbone to protrude, and the nose and lips to get larger.
Publications - Susan L. Samson, M.D., Ph.D. - Mayo Clinic
Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study. BMC Endocr Disord. 2016 Apr 2; 16:16 Epub 2016 Apr 02
Pegvisomant (subcutaneous route) - Mayo Clinic
2024年1月31日 · Pegvisomant is used to treat a condition called acromegaly, which is caused by too much growth hormone in the body, in patients who cannot be treated with surgery or radiation. Too much growth hormone produced in adults causes the hands, feet, and parts of the face to become large, thick, and bulky.
Octreotide (oral route) - Mayo Clinic
Octreotide is used for the long-term treatment of acromegaly (a growth hormone disorder) in patients who have been previously treated with octreotide or lanreotide. This medicine works by reducing the amount of growth hormone that the body produces.
Diagnosis of a rare endocrine disorder in adulthood: A case from …
2021年4月16日 · In patients with MAS, the primary change underlying acromegaly is somatotroph hyperplasia involving the entire pituitary gland, with or without a somatotroph adenoma. Notably, acromegaly is typically associated with skull base FD, which carries an increased risk of hemorrhage due to increased vascularity.
Lanreotide (subcutaneous route) - Mayo Clinic
2024年8月1日 · Lanreotide injection is used for the long-term treatment of acromegaly (a growth hormone disorder) in patients who cannot be treated with surgery or radiation. This medicine works by reducing the amount of growth hormone that the body produces.
What’s a pituitary tumor? 4 things you need to know
2023年3月21日 · Acromegaly: The tumor produces too much growth hormone. Symptoms may include enlarged hands, feet, and facial features in adults, joint pain and muscle weakness, and coarse, oily, thickened skin. Rarely, when it develops in children, it can cause gigantism. If left untreated, patients get diabetes and potentially heart failure from an enlarged ...